Prelude Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-44,677
Closed -$456K 1197
2025
Q1
$456K Buy
44,677
+32,449
+265% +$331K 0.03% 465
2024
Q4
$171K Buy
+12,228
New +$171K 0.01% 898
2020
Q4
Sell
-100
Closed -$25K 1296
2020
Q3
$25K Sell
100
-439
-81% -$110K ﹤0.01% 977
2020
Q2
$187K Buy
+539
New +$187K 0.01% 511
2020
Q1
Sell
-967
Closed -$313K 1353
2019
Q4
$313K Buy
+967
New +$313K 0.01% 429
2019
Q3
Hold
0
1445
2019
Q2
Hold
0
1562
2018
Q4
Sell
-25
Closed -$23K 1633
2018
Q3
$23K Buy
+25
New +$23K ﹤0.01% 949
2018
Q2
Sell
-162
Closed -$259K 1561
2018
Q1
$259K Buy
162
+156
+2,600% +$249K 0.02% 550
2017
Q4
$6K Sell
6
-1,100
-99% -$1.1M ﹤0.01% 1116
2017
Q3
$398K Sell
1,106
-1,940
-64% -$698K 0.04% 387
2017
Q2
$893K Buy
3,046
+1,875
+160% +$550K 0.08% 204
2017
Q1
$412K Buy
1,171
+146
+14% +$51.4K 0.04% 323
2016
Q4
$189K Buy
+1,025
New +$189K 0.02% 568
2016
Q3
Sell
-737
Closed -$157K 1664
2016
Q2
$157K Sell
737
-141
-16% -$30K 0.02% 543
2016
Q1
$181K Sell
878
-2,411
-73% -$497K 0.03% 527
2015
Q4
$831K Buy
3,289
+1,380
+72% +$349K 0.13% 165
2015
Q3
$314K Sell
1,909
-938
-33% -$154K 0.05% 369
2015
Q2
$534K Buy
2,847
+1,066
+60% +$200K 0.07% 271
2015
Q1
$294K Sell
1,781
-63
-3% -$10.4K 0.04% 489
2014
Q4
$429K Buy
1,844
+43
+2% +$10K 0.06% 328
2014
Q3
$326K Sell
1,801
-38
-2% -$6.88K 0.05% 485
2014
Q2
$354K Sell
1,839
-1,528
-45% -$294K 0.05% 443
2014
Q1
$612K Buy
3,367
+1,820
+118% +$331K 0.08% 278
2013
Q4
$263K Hold
1,547
0.04% 490
2013
Q3
$242K Sell
1,547
-2,335
-60% -$365K 0.04% 420
2013
Q2
$673K Buy
+3,882
New +$673K 0.14% 155